Suzhou Highfine Biotech Co., Ltd. (SHE:301393)

Suzhou Highfine Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	551.51	361.08	1,740	99.32	78.05	92.07
Trading Asset Securities	1,153	1,346	30.76	60	45	10
Cash & Short-Term Investments	1,705	1,707	1,770	159.32	123.05	102.07
Cash Growth	-4.06%	-3.56%	1011.12%	29.48%	20.56%	23.44%
Accounts Receivable	126.79	97.16	62.12	53.42	69.11	41.76
Other Receivables	13.25	12.95	1.93	1.71	3.47	0.97
Receivables	140.04	110.12	64.05	55.12	72.58	42.73
Inventory	114.35	116.7	115	113.45	78.89	52.42
Other Current Assets	12.01	10.13	14.69	24.77	15.72	10.14
Total Current Assets	1,971	1,944	1,964	352.67	290.24	207.37
Property, Plant & Equipment	322.11	320.39	286.46	206.24	142.63	81.37
Other Intangible Assets	66.01	66.33	24.02	24.59	25.17	21.99
Long-Term Deferred Tax Assets	4.95	4.39	3.66	3.95	2.37	1.17
Long-Term Deferred Charges	0.08	0.1	0.08	0.26	0.29	0.16
Other Long-Term Assets	22.2	14.14	8.71	12.34	4.4	11.56
Total Assets	2,387	2,350	2,287	600.05	465.09	323.61
Accounts Payable	39.83	27.21	24.9	36.46	25.59	17.34
Accrued Expenses	7.02	17.95	16.68	23.26	15.24	8.71
Short-Term Debt	-	-	-	-	-	1
Current Portion of Leases	1.55	1.68	0.83	1.04	1.03	-
Current Income Taxes Payable	5.54	4.59	3.28	13.94	5.84	1.64
Current Unearned Revenue	1.36	1.38	0.61	0.6	2.34	1.02
Other Current Liabilities	13.58	18.35	19.53	34.04	34.8	27.88
Total Current Liabilities	68.87	71.16	65.84	109.33	84.84	57.59
Long-Term Leases	1.29	1.6	0.72	0.39	1.17	-
Long-Term Unearned Revenue	9.77	7.65	8.45	7.94	6.52	5.2
Long-Term Deferred Tax Liabilities	1.14	0.94	0.07	0.12	-	-
Total Liabilities	81.06	81.35	75.08	117.77	92.53	62.78
Common Stock	108	108	108	81	81	81
Additional Paid-In Capital	1,688	1,686	1,683	54.79	54.79	54.63
Retained Earnings	546.35	511.55	417.69	345.72	236.6	125.2
Treasury Stock	-42	-42	-	-	-	-
Comprehensive Income & Other	5.07	4.44	2.99	0.77	0.18	-
Shareholders' Equity	2,305	2,268	2,212	482.28	372.57	260.83
Total Liabilities & Equity	2,387	2,350	2,287	600.05	465.09	323.61
Total Debt	2.83	3.28	1.56	1.43	2.2	1
Net Cash (Debt)	1,702	1,704	1,769	157.9	120.85	101.07
Net Cash Growth	-4.15%	-3.66%	1020.18%	30.65%	19.58%	22.23%
Net Cash Per Share	15.66	15.76	19.12	1.95	1.50	1.25
Filing Date Shares Outstanding	106.97	106.97	108	81	81	81
Total Common Shares Outstanding	106.97	106.97	108	81	81	81
Working Capital	1,902	1,873	1,898	243.34	205.4	149.78
Book Value Per Share	21.55	21.20	20.48	5.95	4.60	3.22
Tangible Book Value	2,239	2,202	2,188	457.68	347.4	238.84
Tangible Book Value Per Share	20.94	20.58	20.26	5.65	4.29	2.95
Buildings	-	183.65	171.81	74.32	64.69	-
Machinery	-	163.79	76.02	65.92	61.8	16.04
Construction In Progress	-	21.65	72.45	87.92	28.48	74.81

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.